Abstract
Purpose. A model for calculating the circulatory concentrations of fibrinolytic species is proposed and the findings are compared to reported values where available.
Methods. The model uses a CSTR analysis with fourth order Runge-Kutta solution of the differential equations to determine concentration profiles of key fibrinolytic species as a function of time during fibrinolytic therapy. Concentrations of the species are also determined for various dosage regimens of streptokinase and plasminogen.
Results. Data calculated by the model is in agreement with general experimental trends determined in vitro and in vivo.
Conclusions. The proposed model can be used to predict concentration profiles of key fibrinolytic species during administration of streptokinase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
M. I. Dunn and R. J. Dreeling. Archives of Internal Medicine 145:1381 (1981).
M. A. DeWood, J. Spores, R. Notske, L. T. Mouser, R. Burroughs, M. S. Golden, and H. T. Lang. New England Journal of Medicine 303:897 (1980).
V. Bertele and E. W. Salzman. Arteriosclerosis 5:119 March–April (1985).
S. Sherry. American Heart Journal 102:1134 (1981).
S. Yusuf, R. Collins, R. Peto, C. Furberg, M. J. Stampfer, S. Z. Goldhaber, and C. H. Hennekens. European Heart Journal 6:556 (1985).
V. J. Marder. Circulation 68(Sup. 1):I–2 August (1983).
J. Meyer. International Journal of Cardiology 3:447 (1983).
H. K. Gold, R. C. Leinbach, I. F. Palacious, T. Yasuda, P. C. Block, M. J. Buckley, C. W. Akins, W. M. Daggett, and W. G. Austen. Circulation 68(Supp. 1):I–50 mtAugust (1983).
M. Verstraete and D. Collen. Blood 67:1529 (19861).
D. Collen. Thromb. Hemostst. 73:77 (1980).
C. W. Francis and V. J. Marder. Ann. Rev. Med. 37:187 (1986).
R. C. Wohl, L. Summaria, L. Arzadon, and K. C. Robbins. Journal of Biological Chemistry 253:1402 (1978).
D. P. Kosow. Biochemistry 14:4459 (1975).
N. Alkjaersig, A. P. Fletcher, and S. Sherry. Journal of Clinical Investigation 38:1086 (1959).
B. Wiman and D. Collen. European Journal of Biochemistry 84:573 (1978).
S. Diamond and S. Anand. Biophys. J. 65:2622 (1993).
A. Zidansk and A. Blinc. Thromb. and Haemost. 65:553 (1991).
D. O. Cooney. Biomedical Engineering Principles: An Introduction to Fluid, Heat and Mass Transfer Processes, Marcel Dekker Inc., New York, 1976.
J. M. Smith. Chemical Engineering Kinetics, McGraw Hill Book Company Book Company, New York 1981.
B. Carnahan, H. A. Luther, J. O. Wilkes. Applied Numerical Methods, John Wiley and Sons, New York 1969.
W. J. Williams, E. Beulter, A. J. Erslev, M. A. Lichtman, Hematology, McGraw Hill Book Company, New York 1983.
Hoechst Roussel Pharmaceuticals, Strepase Streptokinase, (1987).
Physician's Desk Reference 1991. Medical Economics Company, Ordell, NJ, 1991.
K. N. N. Reddy, B. Cercek, A. S. Lew, and W. Ganz. Thromb. Res. 41:671 (1986).
B. E. Sobel, R. W. Gross, and A. K. Robinson. Circulation 70:160 (1984).
S. A. Cederholm-Williams. Progress in Chemical Fibrinolysis and Thrombolysis, vol. 4, Churchill Livingstone, Edinburgh, 1979.
P. T. Onundarson, H. M. Haraldsson, L. Bergmann, C. W. Francis, and V. J. Marder. Thromb. and Haemost. 70:998–1004 (1993).
A. J. Six, H. W. Louwerenburg, R. Braams, Karel Mechelse, W. L. Mosterd, A. C. Bredero, P. H. J. M. Dunselman, N. M. van Hemel. Am. J. Cardiol. 65:119–123 (1990).
J. D. Gemmill, K. J. Hogg, J. M. A. Burns, A. P. Rae, F. G. Dunn, R. Fears, H. Ferres, R. Standing, H. Greenwood, D. Pierce, and W. S. Hillis. Br. J. Clin. Pharmac. 31:143–147 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tbliani, V.V., O'Rear, E.A. Circulatory Concentrations of Fibrinolytic Species During Thrombolytic Therapy Estimated by Stirred-Tank Reactor Analysis. Pharm Res 14, 1051–1057 (1997). https://doi.org/10.1023/A:1012157429573
Issue Date:
DOI: https://doi.org/10.1023/A:1012157429573